Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak
ACS Nano · 18.08.2026 · 20 (32) · 22696-22715
DOI: 10.1021/acsnano.6c06477 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.08.2026. Verfasst von Jia Shu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory for the Prevention and Treatmen…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Uveitis, Biomimetic Materials, Autoimmune Diseases. Die Arbeit nennt 50 Literaturangaben. Gefördert von: The Science and Technology Cooperation Project of the First Affiliated Hospital of Zhengzhou University, National Natural Science Foundation of China (NSFC), National Natural Science Foundation Key Program.
Abstract (Originalsprache)
Autoimmune uveitis is a recurrent, vision-threatening inflammatory disease that demands precise and ongoing treatment. However, current therapies have limitations in ocular targeting, in controlling reactive oxygen species (ROS), and in regulating key inflammatory pathways. In this study, we develop a mannosylated biomimetic nanocloak (H-151-Cu/Zn-MOF@LM@Man) that combines active targeting, ROS scavenging, and STING pathway inhibition for a synergistic approach to treating autoimmune uveitis. This nanoplatform consists of a copper–zinc bimetallic metal–organic framework (Cu/Zn-MOF) loaded with the STING antagonist H-151 and coated with a hybrid membrane made from macrophage-derived membranes and mannosylated liposomes (LM@Man). After systemic injection, the nanocloak passively homes to inflamed tissues through membrane camouflage and actively targets mannose receptor–expressing immune cells. It efficiently crosses the blood–retinal barrier (BRB) and accumulates at intraocular lesions. At the inflammation site, the Cu/Zn-MOF core scavenges excess ROS using nanozyme activity. At the same time, H-151 inhibits the STING–TBK1–NF-κB pathway, reshaping macrophage and microglia phenotypes, and restoring immune balance. This closed-loop system effectively reduces inflammatory cytokine production, lessens tissue damage, and enhances therapeutic precision. Overall, this study presents a multifunctional, translatable nanoplatform that enables targeted delivery, redox control, and immune reprogramming─offering a promising strategy for treating autoimmune uveitis and other inflammation-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases, Chongqing Branch (Municipality Divis…
- Center for Medical Epigenetics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing400016, China.
- The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Jinfeng Laboratory, Chongqing400016, China.
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai200030, China.
- Department of Ophthalmology, Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, The First Affiliated Hospital of Zhengzhou University, Henan International, Henan Province Eye Hospital, Zhengzhou4…
ORCID-Profile: Siqiao Li, Peizeng Yang
Förderung
- The Science and Technology Cooperation Project of the First Affiliated Hospital of Zhengzhou University
- National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation Key Program
- Natural Science Foundation of Chongqing
- Youth Project of Science and Technology Research Program of Chongqing Education Commission of China
- Chongqing Science and Technology Bureau Mountaineering Project
- The Joint Funds of the National Natural Science Foundation of China
Zitieren
APA
Shu, J., Ling, D., Li, S., Liu, J., Wu, H., Dai, Q., Huang, J., Yang, T., Luo, X., Cao, Q., Su, G., Chen, L., & Yang, P. (2026). Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak. ACS Nano, 20(32), 22696-22715. https://doi.org/10.1021/acsnano.6c06477
Vancouver
Shu J, Ling D, Li S, Liu J, Wu H, Dai Q, et al. Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak. ACS Nano. 2026;20(32):22696-22715. doi:10.1021/acsnano.6c06477
BibTeX
@article{Shu2026,
author = {Shu, Jia and Ling, Doudou and Li, Siqiao and Liu, Jiangyi and Wu, Haiping and Dai, Qinjin and Huang, Jiaxing and Yang, Tao and Luo, Xiang and Cao, Qingfeng and Su, Guannan and Chen, Ling and Yang, Peizeng},
title = {Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {32},
pages = {22696--22715},
doi = {10.1021/acsnano.6c06477}
}
EUVIMED